Literature DB >> 23901082

Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.

Jethro A Herberg1, Myrsini Kaforou, Stuart Gormley, Edward R Sumner, Sanjay Patel, Kelsey D J Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J Wright, Michael Levin.   

Abstract

We compared the blood RNA transcriptome of children hospitalized with influenza A H1N1/09, respiratory syncytial virus (RSV) or bacterial infection, and healthy controls. Compared to controls, H1N1/09 patients showed increased expression of inflammatory pathway genes and reduced expression of adaptive immune pathway genes. This was validated on an independent cohort. The most significant function distinguishing H1N1/09 patients from controls was protein synthesis, with reduced gene expression. Reduced expression of protein synthesis genes also characterized the H1N1/09 expression profile compared to children with RSV and bacterial infection, suggesting that this is a key component of the pathophysiological response in children hospitalized with H1N1/09 infection.

Entities:  

Keywords:  Peptide Chain Initiation; RSV; eIF-2 Kinase; gene expression profiling; influenza; microarray analysis; pediatric; respiratory tract infection

Mesh:

Year:  2013        PMID: 23901082      PMCID: PMC3805235          DOI: 10.1093/infdis/jit348

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


An increased proportion of children admitted with H1N1/09 influenza A (H1N1/09) developed shock, multi-organ failure, and fatal disease than had done so in recent influenza A seasons [1]. Whole blood RNA expression profiling is ideally suited to study emerging infections as it allows interrogation of the host response [2]. Published RNA expression studies of H1N1/09 focused on adults, whose response is influenced by previous exposure [3, 4]. To identify the immunopathogenic responses to H1N1/09 in children, we compared RNA expression in whole blood of prospectively recruited children hospitalized with H1N1/09 infections during the 2009/2010 pandemic.

METHODS

Patient Cohorts

Between July 2009 and June 2010, we recruited 165 febrile children (<17 years) with respiratory infection admitted to St Mary's Hospital London. Whole blood was collected in PAXgene tubes, together with routine clinical samples. Patients were recruited early in their admission, before diagnostic studies were completed, and were assigned to diagnostic categories once results were available (Supplementary Figure 1). The study was approved by St Mary's Research Ethics Committee (REC 09/H0712/58). Written, informed consent was obtained.

Pathogen Diagnosis

Viral diagnostics were undertaken on nasopharyngeal aspirates using immunofluorescence (respiratory syncytial virus [RSV], adenovirus, parainfluenza virus, influenza A + B) and nested polymerase chain reaction (PCR; RSV, coronavirus, adenovirus, parainfluenza 1–4, influenza A + B, bocavirus, metapneumovirus, rhinovirus). Bacterial cultures included blood, cerebrospinal fluid (CSF), urine, and tissue sites. Pneumococcal antigen was measured in blood and urine, and bacterial DNA was detected by meningococcal and pneumococcal PCR.

RNA Expression Profiling

PAXgene tubes were extracted using PAXgene Blood RNA extraction kits (Qiagen). After quantification and quality control, biotin-labeled cRNA was prepared using Illumina TotalPrep RNA Amplification kits (Applied Biosystems). 750 ng labeled cRNA was hybridized to Illumina HumanHT-12v3 BeadChips, and the microarrays scanned. Quality control parameters were assessed using Genome Studio software, visual inspection of the microarray images and principal component analysis (PCA). Two children in the H1N1/09, RSV, and bacterial cohorts had oral or intravenous steroids prior to blood sampling but were not outliers using PCA or unsupervised clustering algorithms (data not shown).

Microarray Analysis

Expression data were analyzed using ‘R’ Language and Environment for Statistical Computing 2.12.1 and GeneSpringGX 11.5 software (Agilent), as described (Supplementary Methods). The data have been deposited in NCBI's Gene Expression Omnibus and are accessible through Series accession number GSE42026 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE42026).

Pathway Analysis

We analyzed 800 network-associated molecules using IPA (Ingenuity Systems, www.ingenuity.com) to identify the most significant biological pathways for differentially expressed genes in each group.

Statistical Analysis of Cohorts

Differences between cohorts in age, proportion of white cell type, and days from illness onset to presentation were calculated using Kruskall-Wallis tests, with Dunn post-test comparisons of each cohort (Graphpad Prism). Differences in gender, severity of illness, and deaths were calculated using χ2 tests of independence (Supplementary Table 1).

RESULTS

Our consecutively recruited cohort included 25 patients with H1N1/09 infection (6 coinfected with other pathogens), 34 with RSV infection (11 coinfected), and 18 with bacterial infection (Supplementary Figure 1). Thirty-three healthy control children were recruited from the outpatients department. Patient demographic and clinical data are summarized in Supplementary Table 1.
Figure 1.

Unsupervised clustering of the top SDE transcripts for (A) H1N1/09 and controls (B) H1N1/09 and RSV and (C) H1N1/09 and bacterial infection. Heatmaps show separation of H1N1/09 and comparator groups by unsupervised Manhattan clustering, based on top SDE transcripts. Each row represents one transcript; each column represents one patient, with a red bar below indicating H1N1/09 and a blue bar a control (A), RSV (B), or bacterial infection (C). Curtailed transcript lists of highly significant probes were used for clarity (P value thresholds of 10−5 (n = 90 transcripts), .002 (n = 97), and .001 (n = 156), respectively, for control, RSV, and bacterial comparisons). Expression intensity is indicated by color (increased abundance in red, decreased in blue, intermediate in yellow).

RNA Expression

When the admission blood RNA expression profile was compared in H1N1/09 patients and controls, we found 1267 significantly differentially expressed (SDE) transcripts (P < .001) (Supplementary Data 1 and 2A) that separated patients and controls on unsupervised clustering analysis (Figure 1A). Using Support Vector Machine (SVM) with leave-one-out validation, strong class prediction sensitivity was achieved (96%; Supplementary Data 1). Unsupervised clustering of the top SDE transcripts for (A) H1N1/09 and controls (B) H1N1/09 and RSV and (C) H1N1/09 and bacterial infection. Heatmaps show separation of H1N1/09 and comparator groups by unsupervised Manhattan clustering, based on top SDE transcripts. Each row represents one transcript; each column represents one patient, with a red bar below indicating H1N1/09 and a blue bar a control (A), RSV (B), or bacterial infection (C). Curtailed transcript lists of highly significant probes were used for clarity (P value thresholds of 10−5 (n = 90 transcripts), .002 (n = 97), and .001 (n = 156), respectively, for control, RSV, and bacterial comparisons). Expression intensity is indicated by color (increased abundance in red, decreased in blue, intermediate in yellow). When patients with RSV or bacterial infection were compared to controls, we identified 1172 and 1869 SDE transcripts (P < .001) respectively (Supplementary Data 1 and 2B and Supplementary DataC). SVM modeling of RNA signatures had sensitivity of 95% and 98% for distinguishing RSV- and bacterial-infected patients respectively (Supplementary Data 1). As the RSV patients were significantly younger than the control or H1N1/09 patients, we compared the RNA expression signature of RSV patients to a subgroup of the youngest controls (n = 10, median age 9 months). The 2411 SDE genes identified (corrected P < .05) were concordant with those identified using all controls: 772 of the top 800 SDE transcripts between RSV and youngest controls were represented, with the same direction of expression, in both data sets.
Figure 2.

Top canonical pathways differing between H1N1/09 and controls, RSV and bacterial infection. Each bar is colored in proportion to the number of SDE H1N1/09 transcripts increased (red) or decreased (green) in abundance relative to the comparator cohort. The total bar length is proportional to P value. Colored blocks next to each pathway are coded according to biological function. Protein synthesis pathways (yellow) were the most significant in all 3 comparisons, with predominant decreased expression in H1N1/09 patients relative to the comparator group. Innate immune pathway transcripts (brown) were increased in H1N1/09 patients, whereas adaptive immune transcripts (pink) were reduced relative to controls.

Identification of Biological Processes in H1N1/09 and Comparator Infections

The biological pathways distinguishing H1N1/09, RSV, and bacterial infections from controls were investigated with IPA, which assigns SDE transcripts to known biological functions and pathways. Biological functions of SDE were enriched for infectious disease, respiratory disease and inflammatory response genes in all 3 groups (Supplementary Data 3). In the H1N1/09 vs controls data set, the functional category “protein synthesis” was significantly over-represented (P = 7.93 × 10−26). Furthermore, the 3 most significant canonical pathways were related to initiation of protein translation: eukaryotic initiation factor 2 (eIF2 - P = 3.16 × 10−25), eukaryotic initiation factor 4 (eIF4 - P = 3.24 × 10−88), and mammalian target of rapamycin (mTOR - P = 1.91 × 10−6) (Supplementary Data 4). Transcripts with increased abundance were enriched for immune response pathways and functions, including signaling from pattern recognition receptors (top increased genes OAS3, C1QB, C1QC), interferon signaling (IFI35, IFIT1, IFT3), and antigen presentation through MHC class I (TAP1, MR1, HLA-B). Transcripts with reduced abundance were enriched for pathways including antigen presentation through MHC class II (most decreased: HLA-DQA, HLA-DPB, HLA-DOA), T-cell signaling and protein synthesis - including those involved in translation, elongation, and ribosomal transport (Supplementary Data 4). There was reduced expression in 63 of 69 SDE transcripts in the eIF2 pathway, P < .0001. Protein synthesis-related transcripts with increased expression included genes with known inhibitory functions in protein synthesis, including EIF2AK2, IFIT1/ISG56, and IFIT2/ISG54 (fold change [FC] of 3.9, 10.0, and 4.0, respectively, in H1N1/09 relative to controls) [5, 6].

Comparison to an Independent Validation Data Set

To validate our findings, we used a publically available adult data set for H1N1/09 and controls [4]. There was complete segregation of H1N1/09 patients and controls when SDE transcripts from our data were used for clustering (Supplementary Figure 2A). When using the SVM prediction model trained on our H1N1/09 vs control data, and applying this to the independent data set, there was 100% sensitivity and specificity of disease and control status. Of 69 transcripts in the top canonical pathway (EIF2 signaling), 32 were SDE in the validation data set (31 with the same direction of regulation; Supplementary Figure 2B).

Comparison of the H1N1/09 Host Response With RSV and Bacterial Infection

To identify unique aspects of the transcription profile of H1N1/09 infection, we compared expression in H1N1/09, RSV, and bacterial infection. Transcripts that were SDE between H1N1/09 and RSV (n = 601 of 7295 transcripts, corrected P < .01) and between H1N1/09 and bacterial infection (n = 734 of 6808 transcripts, corrected P < .01) were used for unsupervised clustering and for classification, H1N1/09 patients were distinguished from RSV (Figure 1B) and bacterial patients (Figure 1C) with accuracy of 93% and 92% for H1N1/09 vs RSV and H1N1/09 vs bacteria, respectively (Supplementary Data 1 and 2D and Supplementary DataE). “Protein synthesis” was the most significant functional category in both the H1N1/09 vs RSV, and H1N1/09 vs bacterial infection data sets (corrected P = 2.73 × 10−13 and 1.6 × 10−11, respectively). The most significant canonical pathways were related to protein synthesis: eIF2 pathway (P = 2.0 × 10−20 and 9.0 × 10−10), eIF4 (P = 4.7 × 10−8 and 0.006), and mTOR (P = 8.1 × 10−7 and 0.016) for H1N1/09 vs RSV, and H1N1/09 vs bacterial infection, respectively (Figure 2 and Supplementary Data 3 and 4). Top canonical pathways differing between H1N1/09 and controls, RSV and bacterial infection. Each bar is colored in proportion to the number of SDE H1N1/09 transcripts increased (red) or decreased (green) in abundance relative to the comparator cohort. The total bar length is proportional to P value. Colored blocks next to each pathway are coded according to biological function. Protein synthesis pathways (yellow) were the most significant in all 3 comparisons, with predominant decreased expression in H1N1/09 patients relative to the comparator group. Innate immune pathway transcripts (brown) were increased in H1N1/09 patients, whereas adaptive immune transcripts (pink) were reduced relative to controls.

DISCUSSION

Marked differences were observed between RNA transcriptional profiles in H1N1/09-infected patients compared to RSV and gram-positive bacterial infection or controls. Patients with H1N1/09 showed increased expression in well-established pathways of the innate antiviral immune response, including pattern recognition receptor, interferon signaling, and myeloid cell activation pathways. Many interferon-induced genes with anti-viral roles showed increased differential expression, including IFI27 (P = 5.8 × 10−11, FC 72.3), and genes implicated in repression of protein synthesis including EIF2AK2, and also IFIT1 and IFIT2, whose anti-viral roles may be mediated through effects on translation [7, 8]. In vitro and murine studies have implicated IFITM3 in restricting influenza replication [9]. Our finding of increased IFITM3 expression (P = 3 × 10−3, FC 6.25) supports its role in H1N1/09 infection. Differences in whole blood RNA expression can reflect altered proportions of cell types and/or altered transcript abundance. Lymphocyte proportion differed significantly only between H1N1/09 and controls (fold change 2.1), whereas the fold change of the top 800 SDE genes used for Ingenuity varied between −6.2 and 72.2. Therefore, differences in lymphocyte proportion do not explain the observed differences, although a role for lymphocyte subset populations is not excluded. H1N1/09 patients showed reduced expression in adaptive immune response pathways, including T-cell activation through NFAT, B cell activation, and MHC class II antigen presentation. Reduced expression of adaptive T- and B-cell pathways may represent a host negative regulatory feedback mechanism [3], or viral-induced immune subversion [10], analogous to viral inhibition of antigen presentation by inhibition of the MHC class II transactivator. The 3 most significant pathways are involved in protein synthesis and translation initiation (eIF2, eIF4, and mTOR), and within these, most genes showed reduced expression. In contrast, inhibitors of translation including EIF2AK2 (which encodes PKR) were upregulated. PKR phosphorylates eukaryotic initiation factor 2 alpha (eIF2a) to cause the arrest of translation initiation [11], suggesting that protein synthesis in H1N1/09 patients may be impaired by repressed transcription of genes required for the translation apparatus, and by increased transcription of translation inhibitors. Reduced expression of protein synthesis genes was significant between H1N1/09 and controls (P = 7.9 × 10−26) and also between H1N1/09 and RSV or bacterial infection (P = 2.73 × 10−13 and 1.6 × 10−11, respectively; Figure 2). In an influenza A challenge study of adult volunteers, differential expression of translation initiation pathway genes was identified in symptomatic but not subclinical infections [12], supporting a role for altered protein synthesis as a key component of the host response to H1N1/09 infection. Increased expression of protein synthesis-inhibiting genes with reduced expression of translation initiation genes is likely to impair protein synthesis. Influenza virus has been observed to shut-off protein synthesis and decrease mRNA levels in infected cells [13], but the phenomenon we have observed in peripheral blood suggests a widespread alteration affecting cells distant from the site of infection. We hypothesize that suppression of protein synthesis may be a distinctive feature of H1N1/09 infection and may play a role in the prolonged debility, fatigue, and delayed recovery seen in severely affected patients. Many of the fatal H1N1/09 cases had acute respiratory distress syndrome requiring prolonged ventilation [1], and late pulmonary hemorrhage or persistent respiratory failure, with death weeks after the acute illness. Suppressed protein synthesis might result in poor tissue recovery and may provide an explanation for the prolonged illness and poor outcome in some patients. In pigs, sepsis impairs protein synthesis through inhibition of mTOR and eIF2 pathways [14]. In culture, H5N1 influenza virus impairs mTOR signaling leading to autophagic cell death [15]. Further studies are required to establish whether the changes we observed in peripheral blood RNA expression are associated with inhibition of protein synthesis and to confirm the role of this phenomenon in severe illness. The changes in expression of genes involved in protein synthesis we have observed may reflect a response to viral components entering the bloodstream, or an indirect effect mediated by host inflammatory molecules. There may be advantages to both virus and host in inhibiting protein synthesis, as immune subversion may occur through impaired leukocyte function, and limitation of production of viral proteins may favor recovery. Limitations in this study include the younger age of the RSV cohort and ethnic variation in the population studied, which was not matched between groups. Furthermore changes in RNA expression during disease may result from altered cell type proportions, as well as upregulation or downregulation of genes. The association of influenza with bacterial infection is well known, and occult bacterial infection may have contributed to disease in some patients. Our comparative study of RNA expression in children with H1N1/09 infection provides information on host response to the pandemic strain. The finding that altered expression of genes involved in protein synthesis is a key feature distinguishing H1N1/09 from other common childhood infections offers a new avenue for investigating the immunopathogenesis of influenza. Click here for additional data file.
  15 in total

1.  Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56.

Authors:  Fulvia Terenzi; Daniel J Hui; William C Merrick; Ganes C Sen
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

2.  Sepsis and development impede muscle protein synthesis in neonatal pigs by different ribosomal mechanisms.

Authors:  Renán A Orellana; Fiona A Wilson; María C Gazzaneo; Agus Suryawan; Teresa A Davis; Hanh V Nguyen
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

3.  A new pathway of translational regulation mediated by eukaryotic initiation factor 3.

Authors:  J Guo; D J Hui; W C Merrick; G C Sen
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

4.  Comparison of pandemic and seasonal influenza reveals higher mortality and increased prevalence of shock in children with severe h1n1/09 infection.

Authors:  Jethro A Herberg; Kelsey D J Jones; Stéphane Paulus; Stuart Gormley; David Muir; Mehrengise Cooper; Michael Levin
Journal:  Pediatr Infect Dis J       Date:  2011-05       Impact factor: 2.129

5.  Gene expression patterns in blood leukocytes discriminate patients with acute infections.

Authors:  Octavio Ramilo; Windy Allman; Wendy Chung; Asuncion Mejias; Monica Ardura; Casey Glaser; Knut M Wittkowski; Bernard Piqueras; Jacques Banchereau; A Karolina Palucka; Damien Chaussabel
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

Review 6.  PERK and PKR: old kinases learn new tricks.

Authors:  Jennifer F Raven; Antonis E Koromilas
Journal:  Cell Cycle       Date:  2008-02-21       Impact factor: 4.534

7.  A distinct influenza infection signature in the blood transcriptome of patients with severe community-acquired pneumonia.

Authors:  Grant P Parnell; Anthony S McLean; David R Booth; Nicola J Armstrong; Marek Nalos; Stephen J Huang; Jan Manak; Wilson Tang; Oi-Yan Tam; Stanley Chan; Benjamin M Tang
Journal:  Crit Care       Date:  2012-08-16       Impact factor: 9.097

8.  2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members.

Authors:  Stephane Daffis; Kristy J Szretter; Jill Schriewer; Jianqing Li; Soonjeon Youn; John Errett; Tsai-Yu Lin; Stewart Schneller; Roland Zust; Hongping Dong; Volker Thiel; Ganes C Sen; Volker Fensterl; William B Klimstra; Theodore C Pierson; R Mark Buller; Michael Gale; Pei-Yong Shi; Michael S Diamond
Journal:  Nature       Date:  2010-11-18       Impact factor: 49.962

9.  Pandemic (H1N1) 2009 influenza virus induces weaker host immune responses in vitro: a possible mechanism of high transmissibility.

Authors:  Sanjay Mukherjee; Veena C Vipat; Akhilesh C Mishra; Shailesh D Pawar; Alok K Chakrabarti
Journal:  Virol J       Date:  2011-03-25       Impact factor: 4.099

10.  Host adaptive immunity deficiency in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Ignacio Martin-Loeches; Jordi Rello; Andres Antón; Raquel Almansa; Luoling Xu; Guillermo Lopez-Campos; Tomás Pumarola; Longsi Ran; Paula Ramirez; David Banner; Derek Cheuk Ng; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Maria J Gómez-Sánchez; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Sara Aldunate; Cristobal León; Pedro Merino; Jesús Blanco; Fernando Martin-Sanchez; Lucia Rico; David Varillas; Veronica Iglesias; Maria Ángeles Marcos; Francisco Gandía; Felipe Bobillo; Begoña Nogueira; Silvia Rojo; Salvador Resino; Carmen Castro; Raul Ortiz de Lejarazu; David Kelvin
Journal:  Crit Care       Date:  2010-09-14       Impact factor: 9.097

View more
  36 in total

1.  EIF3G is associated with narcolepsy across ethnicities.

Authors:  Anja Holm; Ling Lin; Juliette Faraco; Sara Mostafavi; Alexis Battle; Xiaowei Zhu; Douglas F Levinson; Fang Han; Steen Gammeltoft; Poul Jennum; Emmanuel Mignot; Birgitte R Kornum
Journal:  Eur J Hum Genet       Date:  2015-02-11       Impact factor: 4.246

Review 2.  Gene Expression Profiles in Children With Suspected Sepsis.

Authors:  Fran Balamuth; Elizabeth R Alpern; Mengyuan Kan; Maya Shumyatcher; Katie Hayes; Ebbing Lautenbach; Blanca E Himes
Journal:  Ann Emerg Med       Date:  2020-01-23       Impact factor: 5.721

3.  Genomic Circuitry Underlying Immunological Response to Pediatric Acute Respiratory Infection.

Authors:  Sarah E Henrickson; Sasikanth Manne; Douglas V Dolfi; Kathleen D Mansfield; Kaela Parkhouse; Rakesh D Mistry; Elizabeth R Alpern; Scott E Hensley; Kathleen E Sullivan; Susan E Coffin; E John Wherry
Journal:  Cell Rep       Date:  2018-01-09       Impact factor: 9.423

4.  Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger.

Authors:  Prashant Mahajan; Nathan Kuppermann; Asuncion Mejias; Nicolas Suarez; Damien Chaussabel; T Charles Casper; Bennett Smith; Elizabeth R Alpern; Jennifer Anders; Shireen M Atabaki; Jonathan E Bennett; Stephen Blumberg; Bema Bonsu; Dominic Borgialli; Anne Brayer; Lorin Browne; Daniel M Cohen; Ellen F Crain; Andrea T Cruz; Peter S Dayan; Rajender Gattu; Richard Greenberg; John D Hoyle; David M Jaffe; Deborah A Levine; Kathleen Lillis; James G Linakis; Jared Muenzer; Lise E Nigrovic; Elizabeth C Powell; Alexander J Rogers; Genie Roosevelt; Richard M Ruddy; Mary Saunders; Michael G Tunik; Leah Tzimenatos; Melissa Vitale; J Michael Dean; Octavio Ramilo
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

5.  Diagnostic Test Accuracy of a 2-Transcript Host RNA Signature for Discriminating Bacterial vs Viral Infection in Febrile Children.

Authors:  Jethro A Herberg; Myrsini Kaforou; Victoria J Wright; Hannah Shailes; Hariklia Eleftherohorinou; Clive J Hoggart; Miriam Cebey-López; Michael J Carter; Victoria A Janes; Stuart Gormley; Chisato Shimizu; Adriana H Tremoulet; Anouk M Barendregt; Antonio Salas; John Kanegaye; Andrew J Pollard; Saul N Faust; Sanjay Patel; Taco Kuijpers; Federico Martinón-Torres; Jane C Burns; Lachlan J M Coin; Michael Levin
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

6.  Host gene expression classifiers diagnose acute respiratory illness etiology.

Authors:  Ephraim L Tsalik; Ricardo Henao; Marshall Nichols; Thomas Burke; Emily R Ko; Micah T McClain; Lori L Hudson; Anna Mazur; Debra H Freeman; Tim Veldman; Raymond J Langley; Eugenia B Quackenbush; Seth W Glickman; Charles B Cairns; Anja K Jaehne; Emanuel P Rivers; Ronny M Otero; Aimee K Zaas; Stephen F Kingsmore; Joseph Lucas; Vance G Fowler; Lawrence Carin; Geoffrey S Ginsburg; Christopher W Woods
Journal:  Sci Transl Med       Date:  2016-01-20       Impact factor: 17.956

7.  Benchmarking Sepsis Gene Expression Diagnostics Using Public Data.

Authors:  Timothy E Sweeney; Purvesh Khatri
Journal:  Crit Care Med       Date:  2017-01       Impact factor: 7.598

Review 8.  Detecting specific infections in children through host responses: a paradigm shift.

Authors:  Asuncion Mejias; Nicolas M Suarez; Octavio Ramilo
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

9.  Robust classification of bacterial and viral infections via integrated host gene expression diagnostics.

Authors:  Timothy E Sweeney; Hector R Wong; Purvesh Khatri
Journal:  Sci Transl Med       Date:  2016-07-06       Impact factor: 17.956

10.  Kawasaki Disease Patient Stratification and Pathway Analysis Based on Host Transcriptomic and Proteomic Profiles.

Authors:  Heather Jackson; Stephanie Menikou; Shea Hamilton; Andrew McArdle; Chisato Shimizu; Rachel Galassini; Honglei Huang; Jihoon Kim; Adriana Tremoulet; Adam Thorne; Roman Fischer; Marien I de Jonge; Taco Kuijpers; Victoria Wright; Jane C Burns; Climent Casals-Pascual; Jethro Herberg; Mike Levin; Myrsini Kaforou
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.